Studying characteristics of idiopathic pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This study looks at the symptoms and patterns of idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. By joining, you help doctors better understand the disease, which may lead to better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of idiopathic pulmonary fibrosis (IPF).
- You must be at least 18 years old.
- You must be able to understand the study and give your consent.
- You must be able to care for yourself and not be confined to bed.
- You must not have confusion, dementia, or a serious mental illness.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with idiopathic pulmonary fibrosis (IPF) to learn how traditional Chinese medicine may help. By joining, you help researchers understand better ways to manage this lung condition.
This study looks at genetic (inherited) factors related to pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF). It may help researchers understand why some families are more affected and could guide future testing or treatments.
This trial tests a new drug called BC006 for people with idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring. The goal is to see if it can help improve lung function. You may be eligible if you are 40 or older and have a confirmed IPF diagnosis with specific lung test results.
This study looks at genetic differences in people with idiopathic pulmonary fibrosis (a lung scarring condition with no known cause). It may help researchers understand what influences the disease and guide future treatment options.
This study looks at people with a condition called idiopathic pulmonary fibrosis (IPF), which causes lung scarring. Researchers want to develop a tool to predict how the disease will progress, so they will collect health data over time to see what factors affect outcomes.
This study looks at what causes familial (inherited) pulmonary fibrosis by studying relatives who are not yet diagnosed with the lung disease. You may help researchers understand risk and early changes in the lungs within families.
Hear when a new Idiopathic Pulmonary Fibrosis (IPF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.